Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
DARE

Dare Bioscience

$1.07

(0.00%)

07:56
05/16/18
05/16
07:56
05/16/18
07:56
Initiation
Dare Bioscience initiated at Roth Capital »

Dare Bioscience initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DARE

Dare Bioscience

$1.07

-0.03 (-2.73%)

08:05
05/15/18
05/15
08:05
05/15/18
08:05
Hot Stocks
Dare Bioscience announces trial initiation for Ovaprene »

Dare Bioscience announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DARE

Dare Bioscience

$1.20

(0.00%)

09:40
05/08/18
05/08
09:40
05/08/18
09:40
Hot Stocks
Dare Bioscience appoints John Fair as Chief Business Officer »

Dare Bioscience announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DARE

Dare Bioscience

$1.07

0.03 (2.88%)

08:22
05/07/18
05/07
08:22
05/07/18
08:22
Hot Stocks
Dare Bioscience agrees to acquire Pear Tree Pharmaceuticals »

Dare Bioscience announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a month ago
DARE

Dare Bioscience

$0.82

0.0054 (0.67%)

08:13
04/25/18
04/25
08:13
04/25/18
08:13
Hot Stocks
Dare Bioscience, Juniper emter into exclusive worldwide license agreement »

Dare Bioscience announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNP

Juniper Pharmaceuticals

$8.10

-0.6 (-6.90%)

, DARE

Dare Bioscience

$0.82

0.0054 (0.67%)

08:05
04/25/18
04/25
08:05
04/25/18
08:05
Hot Stocks
Juniper Pharmaceuticals licenses intravaginal ring platform to Dare Bioscience »

Juniper Pharmaceuticals…

JNP

Juniper Pharmaceuticals

$8.10

-0.6 (-6.90%)

DARE

Dare Bioscience

$0.82

0.0054 (0.67%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INNV

Innovus Pharmaceuticals

$0.00

(0.00%)

, DARE

Dare Bioscience

$0.84

-0.0552 (-6.17%)

06:02
04/23/18
04/23
06:02
04/23/18
06:02
Hot Stocks
Innovus Pharmaceuticals names Ryan Selhorn as CFO »

Innovus Pharmaceuticals…

INNV

Innovus Pharmaceuticals

$0.00

(0.00%)

DARE

Dare Bioscience

$0.84

-0.0552 (-6.17%)

MNOV

MediciNova

$11.20

-0.39 (-3.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    May

  • 21

    May

DARE

Dare Bioscience

$0.83

-0.0589 (-6.62%)

04:55
03/29/18
03/29
04:55
03/29/18
04:55
Conference/Events
Dare Bioscience management to meet with Roth Capital »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Mar

DARE

Dare Bioscience

$0.95

-0.02 (-2.06%)

10:03
03/26/18
03/26
10:03
03/26/18
10:03
Conference/Events
Dare Bioscience management to meet with Roth Capital »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Mar

DARE

Dare Bioscience

$1.27

-0.02 (-1.55%)

08:15
03/12/18
03/12
08:15
03/12/18
08:15
Hot Stocks
Dare Bioscience announces exclusive development, option agreement with Orbis »

Dare Bioscience announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.